Clinical Trial Update: Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of bortezomib in combination with gemcitabine and doxorubicin for urothelial cancer and other solid tumors; the study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urethral Cancer
• Urothelial Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• Doxorubicin (doxorubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumor, Urethral Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING